Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Fat storage-inducing transmembrane protein 1 (FITM1, FIT1) is an evolutionarily conserved integral membrane protein that plays a key role in the formation of lipid droplets, which are cellular organelles central to lipid and energy storage. FITM1 functions by binding diacylglycerol and triglycerides, partitioning newly synthesized triglycerides into lipid droplets without directly catalyzing triglyceride synthesis. It is predicted to localize primarily to the endoplasmic reticulum membrane. While FITM1 has a role in fat storage and may contribute to cellular energy balance, it is not currently considered a primary therapeutic target, and there are no known drugs that act on this protein.
Not applicable (No known drugs target FITM1 directly)
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Fat storage-inducing transmembrane protein 1 (FITM1).